{
  "DOI": "10.1038/ejhg.2012.222",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2012.222",
  "alternative-id": [
    "BFejhg2012222"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Schreml",
      "given": "Julia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Riessland",
      "given": "Markus",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Paterno",
      "given": "Mario",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Garbes",
      "given": "Lutz",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roßbach",
      "given": "Kristina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ackermann",
      "given": "Bastian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Krämer",
      "given": "Jan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Somers",
      "given": "Eilidh",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Parson",
      "given": "Simon H",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Heller",
      "given": "Raoul",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berkessel",
      "given": "Albrecht",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sterner-Kock",
      "given": "Anja",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wirth",
      "given": "Brunhilde",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        10,
        17
      ]
    ],
    "date-time": "2012-10-17T10:40:59Z",
    "timestamp": 1350470459000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:06:41Z",
    "timestamp": 1684429601000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        15
      ]
    ],
    "date-time": "2024-04-15T07:33:37Z",
    "timestamp": 1713166417254
  },
  "is-referenced-by-count": 52,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2012,
        10,
        17
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2013,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2012,
            10,
            17
          ]
        ],
        "date-time": "2012-10-17T00:00:00Z",
        "timestamp": 1350432000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2012222.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2012222",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2012222.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "643-652",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2012,
        10,
        17
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        10,
        17
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1006/nbdi.1996.0010",
      "author": "TO Crawford",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Neurobiol Dis",
      "key": "BFejhg2012222_CR1",
      "unstructured": "Crawford TO, Pardo CA : The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996; 3: 97–110.",
      "volume": "3",
      "year": "1996"
    },
    {
      "DOI": "10.1086/338627",
      "author": "M Feldkotter",
      "doi-asserted-by": "publisher",
      "first-page": "358",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2012222_CR2",
      "unstructured": "Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B : Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358–368.",
      "volume": "70",
      "year": "2002"
    },
    {
      "DOI": "10.1007/BF00212036",
      "author": "A Thieme",
      "doi-asserted-by": "publisher",
      "first-page": "344",
      "journal-title": "Hum Genet",
      "key": "BFejhg2012222_CR3",
      "unstructured": "Thieme A, Mitulla B, Schulze F, Spiegler AW : Chronic childhood spinal muscular atrophy in Germany (West-Thuringen)--an epidemiological study. Hum Genet 1994; 93: 344–346.",
      "volume": "93",
      "year": "1994"
    },
    {
      "DOI": "10.1016/0092-8674(95)90460-3",
      "author": "S Lefebvre",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Cell",
      "key": "BFejhg2012222_CR4",
      "unstructured": "Lefebvre S, Burglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155–165.",
      "volume": "80",
      "year": "1995"
    },
    {
      "DOI": "10.1002/(SICI)1098-1004(200003)15:3\u003c228::AID-HUMU3\u003e3.0.CO;2-9",
      "author": "B Wirth",
      "doi-asserted-by": "publisher",
      "first-page": "228",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2012222_CR5",
      "unstructured": "Wirth B : An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 2000; 15: 228–237.",
      "volume": "15",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s00439-008-0598-1",
      "author": "L Alias",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Hum Genet",
      "key": "BFejhg2012222_CR6",
      "unstructured": "Alias L, Bernal S, Fuentes-Prior P et al: Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 2009; 125: 29–39.",
      "volume": "125",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0960-8966(06)80015-5",
      "author": "TL Munsat",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2012222_CR7",
      "unstructured": "Munsat TL, Davies KE : International SMA consortium meeting. (26–28 June 1992, Bonn, Germany). Neuromuscul Disord 1992; 2: 423–428.",
      "volume": "2",
      "year": "1992"
    },
    {
      "DOI": "10.1086/515465",
      "author": "PE McAndrew",
      "doi-asserted-by": "publisher",
      "first-page": "1411",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2012222_CR8",
      "unstructured": "McAndrew PE, Parsons DW, Simard LR et al: Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60: 1411–1422.",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1007/s00439-006-0156-7",
      "author": "B Wirth",
      "doi-asserted-by": "publisher",
      "first-page": "422",
      "journal-title": "Hum Genet",
      "key": "BFejhg2012222_CR9",
      "unstructured": "Wirth B, Brichta L, Schrank B et al: Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 2006; 119: 422–428.",
      "volume": "119",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng1207",
      "author": "T Kashima",
      "doi-asserted-by": "publisher",
      "first-page": "460",
      "journal-title": "Nat Genet",
      "key": "BFejhg2012222_CR10",
      "unstructured": "Kashima T, Manley JL : A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34: 460–463.",
      "volume": "34",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.96.11.6307",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "6307",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2012222_CR11",
      "unstructured": "Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307–6311.",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1038/ng854",
      "author": "L Cartegni",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "journal-title": "Nat Genet",
      "key": "BFejhg2012222_CR12",
      "unstructured": "Cartegni L, Krainer AR : Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30: 377–384.",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s00439-003-1025-2",
      "author": "C Helmken",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Hum Genet",
      "key": "BFejhg2012222_CR13",
      "unstructured": "Helmken C, Hofmann Y, Schoenen F et al: Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003; 114: 11–21.",
      "volume": "114",
      "year": "2003"
    },
    {
      "DOI": "10.1093/hmg/9.2.259",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR14",
      "unstructured": "Lorson CL, Androphy EJ : An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000; 9: 259–265.",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1007/978-3-540-34449-0_6",
      "author": "B Wirth",
      "doi-asserted-by": "publisher",
      "first-page": "109",
      "journal-title": "Prog Mol Subcell Biol",
      "key": "BFejhg2012222_CR15",
      "unstructured": "Wirth B, Brichta L, Hahnen E : Spinal muscular atrophy and therapeutic prospects. Prog Mol Subcell Biol 2006; 44: 109–132.",
      "volume": "44",
      "year": "2006"
    },
    {
      "DOI": "10.1093/hmg/ddq147",
      "author": "CL Lorson",
      "doi-asserted-by": "publisher",
      "first-page": "R111",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR16",
      "unstructured": "Lorson CL, Rindt H, Shababi M : Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 2010; 19: R111–R118.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11940-009-0012-x",
      "author": "BG Burnett",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "Curr Treat Options Neurol",
      "key": "BFejhg2012222_CR17",
      "unstructured": "Burnett BG, Crawford TO, Sumner CJ : Emerging treatment options for spinal muscular atrophy. Curr Treat Options Neurol 2009; 11: 90–101.",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nature10485",
      "author": "Y Hua",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Nature",
      "key": "BFejhg2012222_CR18",
      "unstructured": "Hua Y, Sahashi K, Rigo F et al: Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011; 478: 123–126.",
      "volume": "478",
      "year": "2011"
    },
    {
      "DOI": "10.1002/14651858.CD006282.pub3",
      "doi-asserted-by": "crossref",
      "key": "BFejhg2012222_CR19",
      "unstructured": "Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF : Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev 2011; 12 ( CD006282)."
    },
    {
      "DOI": "10.1002/14651858.CD006281.pub3",
      "doi-asserted-by": "crossref",
      "key": "BFejhg2012222_CR20",
      "unstructured": "Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF : Drug treatment for spinal muscular atrophy type I. Cochrane Database Syst Rev 2011; 12 ( CD006281)."
    },
    {
      "DOI": "10.1002/ana.20836",
      "author": "L Brichta",
      "doi-asserted-by": "publisher",
      "first-page": "970",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2012222_CR21",
      "unstructured": "Brichta L, Holker I, Haug K, Klockgether T, Wirth B : In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 2006; 59: 970–975.",
      "volume": "59",
      "year": "2006"
    },
    {
      "DOI": "10.1093/hmg/ddg256",
      "author": "L Brichta",
      "doi-asserted-by": "publisher",
      "first-page": "2481",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR22",
      "unstructured": "Brichta L, Hofmann Y, Hahnen E et al: Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481–2489.",
      "volume": "12",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ana.10743",
      "author": "CJ Sumner",
      "doi-asserted-by": "publisher",
      "first-page": "647",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2012222_CR23",
      "unstructured": "Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647–654.",
      "volume": "54",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1471-4159.2006.03868.x",
      "author": "E Hahnen",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "journal-title": "J Neurochem",
      "key": "BFejhg2012222_CR24",
      "unstructured": "Hahnen E, Eyupoglu IY, Brichta L et al: In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem 2006; 98: 193–202.",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s00439-006-0186-1",
      "author": "M Riessland",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Hum Genet",
      "key": "BFejhg2012222_CR25",
      "unstructured": "Riessland M, Brichta L, Hahnen E, Wirth B : The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells. Hum Genet 2006; 120: 101–110.",
      "volume": "120",
      "year": "2006"
    },
    {
      "DOI": "10.1093/hmg/ddp313",
      "author": "L Garbes",
      "doi-asserted-by": "publisher",
      "first-page": "3645",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR26",
      "unstructured": "Garbes L, Riessland M, Holker I et al: LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet 2009; 18: 3645–3658.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.171105098",
      "author": "JG Chang",
      "doi-asserted-by": "publisher",
      "first-page": "9808",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2012222_CR27",
      "unstructured": "Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808–9813.",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/ddi130",
      "author": "LE Kernochan",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR28",
      "unstructured": "Kernochan LE, Russo ML, Woodling NS et al: The role of histone acetylation in SMN gene expression. Hum Mol Genet 2005; 14: 1171–1182.",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1172/JCI29562",
      "author": "AM Avila",
      "doi-asserted-by": "publisher",
      "first-page": "659",
      "journal-title": "J Clin Invest",
      "key": "BFejhg2012222_CR29",
      "unstructured": "Avila AM, Burnett BG, Taye AA et al: Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 2007; 117: 659–671.",
      "volume": "117",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/ddq023",
      "author": "M Riessland",
      "doi-asserted-by": "publisher",
      "first-page": "2154",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR30",
      "unstructured": "Riessland M, Ackermann B, Forster A et al: SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 2010; 19: 2154–2167.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s00109-008-0388-1",
      "author": "LK Tsai",
      "doi-asserted-by": "publisher",
      "first-page": "1243",
      "journal-title": "J Mol Med",
      "key": "BFejhg2012222_CR31",
      "unstructured": "Tsai LK, Tsai MS, Ting CH, Li H : Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice. J Mol Med 2008; 86: 1243–1254.",
      "volume": "86",
      "year": "2008"
    },
    {
      "DOI": "10.1136/jnnp.2009.200253",
      "author": "S Piepers",
      "doi-asserted-by": "publisher",
      "first-page": "850",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "BFejhg2012222_CR32",
      "unstructured": "Piepers S, Cobben JM, Sodaar P et al: Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid. J Neurol Neurosurg Psychiatry 2011; 82: 850–852.",
      "volume": "82",
      "year": "2011"
    },
    {
      "DOI": "10.1212/01.wnl.0000231139.26253.d0",
      "author": "CC Weihl",
      "doi-asserted-by": "publisher",
      "first-page": "500",
      "journal-title": "Neurology",
      "key": "BFejhg2012222_CR33",
      "unstructured": "Weihl CC, Connolly AM, Pestronk A : Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy. Neurology 2006; 67: 500–501.",
      "volume": "67",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.pone.0021296",
      "author": "JT Kissel",
      "doi-asserted-by": "publisher",
      "first-page": "e21296",
      "journal-title": "PLoS One",
      "key": "BFejhg2012222_CR34",
      "unstructured": "Kissel JT, Scott CB, Reyna SP et al: SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy. PLoS One 2011; 6: e21296.",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0012140",
      "author": "KJ Swoboda",
      "doi-asserted-by": "publisher",
      "first-page": "e12140",
      "journal-title": "PLoS One",
      "key": "BFejhg2012222_CR35",
      "unstructured": "Swoboda KJ, Scott CB, Crawford TO et al: SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. PLoS One 2011; 5: e12140.",
      "volume": "5",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.leukres.2009.07.024",
      "author": "WG Tong",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "journal-title": "Leuk Res",
      "key": "BFejhg2012222_CR36",
      "unstructured": "Tong WG, Wei Y, Stevenson W et al: Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor. Leuk Res 2010; 34: 221–228.",
      "volume": "34",
      "year": "2010"
    },
    {
      "DOI": "10.1038/leu.2009.121",
      "author": "S Deleu",
      "doi-asserted-by": "publisher",
      "first-page": "1894",
      "journal-title": "Leukemia",
      "key": "BFejhg2012222_CR37",
      "unstructured": "Deleu S, Lemaire M, Arts J et al: The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models. Leukemia 2009; 23: 1894–1903.",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-0547",
      "author": "J Arts",
      "doi-asserted-by": "publisher",
      "first-page": "6841",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2012222_CR38",
      "unstructured": "Arts J, King P, Marien A et al: JNJ-26481585, a novel ‘second-generation’ oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. Clin Cancer Res 2009; 15: 6841–6851.",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1365-2141.2010.08126.x",
      "author": "T Stuhmer",
      "doi-asserted-by": "publisher",
      "first-page": "529",
      "journal-title": "Br J Haematol",
      "key": "BFejhg2012222_CR39",
      "unstructured": "Stuhmer T, Arts J, Chatterjee M et al: Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585. Br J Haematol 2010; 149: 529–536.",
      "volume": "149",
      "year": "2010"
    },
    {
      "DOI": "10.1038/71709",
      "author": "HM Hsieh-Li",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "journal-title": "Nat Genet",
      "key": "BFejhg2012222_CR40",
      "unstructured": "Hsieh-Li HM, Chang JG, Jong YJ et al: A mouse model for spinal muscular atrophy. Nat Genet 2000; 24: 66–70.",
      "volume": "24",
      "year": "2000"
    },
    {
      "DOI": "10.1002/ajmg.a.32233",
      "author": "LA Menke",
      "doi-asserted-by": "publisher",
      "first-page": "740",
      "journal-title": "Am J Med Genet A",
      "key": "BFejhg2012222_CR41",
      "unstructured": "Menke LA, Poll-The BT, Clur SA et al: Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. Am J Med Genet A 2008; 146A: 740–744.",
      "volume": "146A",
      "year": "2008"
    },
    {
      "DOI": "10.1093/hmg/ddq330",
      "author": "CR Heier",
      "doi-asserted-by": "publisher",
      "first-page": "3906",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR42",
      "unstructured": "Heier CR, Satta R, Lutz C, DiDonato CJ : Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 2010; 19: 3906–3918.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1093/hmg/ddq329",
      "author": "M Shababi",
      "doi-asserted-by": "publisher",
      "first-page": "4059",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR43",
      "unstructured": "Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL : Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 2010; 19: 4059–4071.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1136/jmg.2008.057950",
      "author": "S Rudnik-Schoneborn",
      "doi-asserted-by": "publisher",
      "first-page": "635",
      "journal-title": "J Med Genet",
      "key": "BFejhg2012222_CR44",
      "unstructured": "Rudnik-Schoneborn S, Heller R, Berg C et al: Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J Med Genet 2008; 45: 635–638.",
      "volume": "45",
      "year": "2008"
    },
    {
      "DOI": "10.1093/hmg/ddr360",
      "author": "CA Mutsaers",
      "doi-asserted-by": "publisher",
      "first-page": "4334",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR45",
      "unstructured": "Mutsaers CA, Wishart TM, Lamont DJ et al: Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet 2011; 20: 4334–4344.",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.nmd.2011.10.021",
      "author": "E Somers",
      "doi-asserted-by": "publisher",
      "first-page": "435",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2012222_CR46",
      "unstructured": "Somers E, Stencel Z, Wishart TM, Gillingwater TH, Parson SH : Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy. Neuromuscul Disord 2012; 22: 435–442.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1093/hmg/ddq094",
      "author": "Y Mende",
      "doi-asserted-by": "publisher",
      "first-page": "2154",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR47",
      "unstructured": "Mende Y, Jakubik M, Riessland M et al: Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing. Hum Mol Genet 2010; 19: 2154–2167.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.expneurol.2008.02.025",
      "author": "BF El-Khodor",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Exp Neurol",
      "key": "BFejhg2012222_CR48",
      "unstructured": "El-Khodor BF, Edgar N, Chen A et al: Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. Exp Neurol 2008; 212: 29–43.",
      "volume": "212",
      "year": "2008"
    },
    {
      "DOI": "10.1093/hmg/ddm367",
      "author": "LM Murray",
      "doi-asserted-by": "publisher",
      "first-page": "949",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR49",
      "unstructured": "Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH : Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008; 17: 949–962.",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1093/hmg/ddn357",
      "author": "J Hauke",
      "doi-asserted-by": "publisher",
      "first-page": "304",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR50",
      "unstructured": "Hauke J, Riessland M, Lunke S et al: Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 2009; 18: 304–317.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1038/onc.2009.306",
      "author": "E Borbone",
      "doi-asserted-by": "publisher",
      "first-page": "105",
      "journal-title": "Oncogene",
      "key": "BFejhg2012222_CR51",
      "unstructured": "Borbone E, Berlingieri MT, De Bellis F et al: Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. Oncogene 2012; 29: 105–116.",
      "volume": "29",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.biopha.2011.06.007",
      "author": "A Yeung",
      "doi-asserted-by": "publisher",
      "first-page": "232",
      "journal-title": "Biomed Pharmacother",
      "key": "BFejhg2012222_CR52",
      "unstructured": "Yeung A, Bhargava RK, Ahn R et al: HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation. Biomed Pharmacother 2010; 66: 232–236.",
      "volume": "66",
      "year": "2010"
    },
    {
      "DOI": "10.1126/scitranslmed.3001777",
      "author": "MA Passini",
      "doi-asserted-by": "publisher",
      "first-page": "72ra18",
      "journal-title": "Sci Transl Med",
      "key": "BFejhg2012222_CR53",
      "unstructured": "Passini MA, Bu J, Richards AM et al: Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 2011; 3: 72ra18.",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.nmd.2011.09.007",
      "author": "M Bowerman",
      "doi-asserted-by": "publisher",
      "first-page": "263",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2012222_CR54",
      "unstructured": "Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R : A critical Smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul Disord 2012; 22: 263–276.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1093/hmg/ddp506",
      "author": "LM Murray",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR55",
      "unstructured": "Murray LM, Lee S, Baumer D, Parson SH, Talbot K, Gillingwater TH : Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 2010; 19: 420–433.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1093/hmg/ddr600",
      "author": "PN Porensky",
      "doi-asserted-by": "publisher",
      "first-page": "1625",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR56",
      "unstructured": "Porensky PN, Mitrpant C, McGovern VL et al: A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 2012; 21: 1625–1638.",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1101/gad.197418.112",
      "author": "K Sahashi",
      "doi-asserted-by": "publisher",
      "first-page": "1874",
      "journal-title": "Genes Dev",
      "key": "BFejhg2012222_CR57",
      "unstructured": "Sahashi K, Hua Y, Ling KK et al: TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals. Genes Dev 2012; 26: 1874–1884.",
      "volume": "26",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cmet.2011.03.020",
      "author": "SD Kunkel",
      "doi-asserted-by": "publisher",
      "first-page": "627",
      "journal-title": "Cell Metab",
      "key": "BFejhg2012222_CR58",
      "unstructured": "Kunkel SD, Suneja M, Ebert SM et al: mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 2011; 13: 627–638.",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/ddr067",
      "author": "M Bosch-Marce",
      "doi-asserted-by": "publisher",
      "first-page": "1844",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR59",
      "unstructured": "Bosch-Marce M, Wee CD, Martinez TL et al: Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum Mol Genet 2011; 20: 1844–1853.",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1177/0883073807304009",
      "author": "N Yuan",
      "doi-asserted-by": "publisher",
      "first-page": "727",
      "journal-title": "J Child Neurol",
      "key": "BFejhg2012222_CR60",
      "unstructured": "Yuan N, Wang CH, Trela A, Albanese CT : Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy. J Child Neurol 2007; 22: 727–731.",
      "volume": "22",
      "year": "2007"
    },
    {
      "author": "D Karasick",
      "first-page": "475",
      "journal-title": "J Natl Med Assoc",
      "key": "BFejhg2012222_CR61",
      "unstructured": "Karasick D, Karasick S, Mapp E : Gastrointestinal radiologic manifestations of proximal spinal muscular atrophy (Kugelberg-Welander syndrome). J Natl Med Assoc 1982; 74: 475–478.",
      "volume": "74",
      "year": "1982"
    },
    {
      "DOI": "10.1002/mus.880170816",
      "author": "V Ionasescu",
      "doi-asserted-by": "publisher",
      "first-page": "946",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2012222_CR62",
      "unstructured": "Ionasescu V, Christensen J, Hart M : Intestinal pseudo-obstruction in adult spinal muscular atrophy. Muscle Nerve 1994; 17: 946–948.",
      "volume": "17",
      "year": "1994"
    },
    {
      "DOI": "10.1097/SPC.0b013e3282f31667",
      "author": "M Lainscak",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "journal-title": "Curr Opin Support Palliat Care",
      "key": "BFejhg2012222_CR63",
      "unstructured": "Lainscak M, Podbregar M, Anker SD : How does cachexia influence survival in cancer, heart failure and other chronic diseases? Curr Opin Support Palliat Care 2007; 1: 299–305.",
      "volume": "1",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/ddq300",
      "author": "AK Bevan",
      "doi-asserted-by": "publisher",
      "first-page": "3895",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2012222_CR64",
      "unstructured": "Bevan AK, Hutchinson KR, Foust KD et al: Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet 2010; 19: 3895–3905.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1540-8167.2008.01327.x",
      "author": "M Roos",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "journal-title": "J Cardiovasc Electrophysiol",
      "key": "BFejhg2012222_CR65",
      "unstructured": "Roos M, Sarkozy A, Chierchia GB, De Wilde P, Schmedding E, Brugada P : Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy (Kugelberg-Welander disease). J Cardiovasc Electrophysiol 2009; 20: 342–344.",
      "volume": "20",
      "year": "2009"
    },
    {
      "DOI": "10.1097/00000441-200612000-00009",
      "author": "N Takahashi",
      "doi-asserted-by": "publisher",
      "first-page": "354",
      "journal-title": "Am J Med Sci",
      "key": "BFejhg2012222_CR66",
      "unstructured": "Takahashi N, Shimada T, Ishibashi Y et al: Cardiac involvement in Kugelberg-Welander disease: a case report and review. Am J Med Sci 2006; 332: 354–356.",
      "volume": "332",
      "year": "2006"
    },
    {
      "DOI": "10.1177/0883073807299954",
      "author": "E Vaidla",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "J Child Neurol",
      "key": "BFejhg2012222_CR67",
      "unstructured": "Vaidla E, Talvik I, Kulla A et al: Neonatal spinal muscular atrophy type 1 with bone fractures and heart defect. J Child Neurol 2007; 22: 67–70.",
      "volume": "22",
      "year": "2007"
    },
    {
      "DOI": "10.1146/annurev.neuro.28.061604.135659",
      "author": "NO Glebova",
      "doi-asserted-by": "publisher",
      "first-page": "191",
      "journal-title": "Annu Rev Neurosci",
      "key": "BFejhg2012222_CR68",
      "unstructured": "Glebova NO, Ginty DD : Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 2005; 28: 191–222.",
      "volume": "28",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0896-6273(02)00774-2",
      "author": "Y Honma",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Neuron",
      "key": "BFejhg2012222_CR69",
      "unstructured": "Honma Y, Araki T, Gianino S et al: Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron 2002; 35: 267–282.",
      "volume": "35",
      "year": "2002"
    }
  ],
  "reference-count": 69,
  "references-count": 69,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2012222"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585"
  ],
  "type": "journal-article",
  "volume": "21"
}